From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit

MP Lythgoe, J Krell, M Bower, R Murphy… - The Lancet …, 2023 - thelancet.com
The departure of the UK from the European Union (EU) and affiliated European regulatory
bodies, including the European Medicines Agency, on Dec 31, 2020, has resulted in the …

The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access

AM IVAMA-BRUMMELL… - … e Serviços de …, 2022 - rbfhss.emnuvens.com.br
Abstract The United Kingdom has universal healthcare systems, the National Health System
(NHS), in its four nations, with healthcare services provided free of charge at the point of …

[HTML][HTML] Trent'anni di EBM: cosa è cambiato, cosa deve ancora cambiare

G Formoso - Recenti Progressi in Medicina, 2022 - recentiprogressi.it
In generale, medicina basata sulle prove e pratica clinica non devono essere viste come
due entità in contrapposizione. La prima suggerisce alcune regole per la realizzazione e la …

[引用][C] Pharmaceutical Policy in the UK